CTNMのROE（自己資本利益率）は？

Contineum Therapeutics, Inc. Class A Common StockのROEは-24.02%です。

CTNMの配当利回りは？

Contineum Therapeutics, Inc. Class A Common Stockの配当利回りは0.00%です。

CTNMの品質スコア（Quality Score）は？

当社のAIはCTNMの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

CTNMは今が買い時ですか？

当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

CTNMはどのセクターに属しますか？

Contineum Therapeutics, Inc. Class A Common StockはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

CTNM (NASDAQ) 株価分析 | CONTINEUM THERAPEUTICS, INC. CLASS A COMMON STOCK

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-06-30)

CTNM AI Analysis Summary

Our AI summary for CTNM: Contineum Therapeutics, Inc. Class A Common Stock (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -24.02%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

CTNM

Contineum Therapeutics, Inc. Class A Common Stock

US:NASDAQ STOCK Healthcare >> Biotechnology News 88

USD 15.90

-0.03 (-0.19%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-24.0%

ROE

-23.0%

ROA

0.00%

Div Yield

CONTINEUM THERAPEUTICS, INC. CLASS A COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 15.90 Price -0.03 (-0.19%) Day Change	NEWS SCORE: 88

CTNM, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

39%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	88
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	15.90
PBV / Sector	2.50 / 44,022.72
Earning Per Share	-1.53

PE / Sector	N/A / 19.17
PEG or PE/Growth / Sector	N/A / 1.24
Average 1M Daily Value	3.80 M GREAT
Average 1W Daily Value	5.26 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.24
NPM Average (%) / Sector	45.44 / -1,697.63 GREAT
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-22.99 / 185,260.96
ROA Average (%) / Sector	-19.00 / 36,684.70
ROA Change Average (%) / Sector	-83.77 / 422,221.66
ROE (%) / Sector	-24.02 / 243,762.23
ROE Average (%) / Sector	-32.71 / 48,758.47
ROE Change Average (%) / Sector	-17.46 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

登録情報

Analyze Date	2026-08-05 08:00:02
Symbol	CTNM
Name	CONTINEUM THERAPEUTICS, INC. CLASS A COMMON STOCK
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	32.96 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	599.30 / 9,586.08

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 3565 General Atomics Court, San Diego, CA, United States, 92121

Phone: 858 333 5280

Website: https://www.contineum-tx.com

Employees: 51

Sector: Healthcare >> Biotechnology

Description: Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company's lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California.